Nonclinical Safety Evaluation of Reformulated Drug Products and Products Intended for Administration by an Alternate Route
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 28, 2015
May 14, 2020
4ff25d70-5ac4-418c-a83e-79f958421f2c
Related Documents
Osteoporosis: Nonclinical Evaluation of Drugs Intended for Treatment Guidance for Industry: Guidance for Industry
Guidance DocumentAugust 15, 2019Center for Drug Evaluation and Research
Uncomplicated Gonorrhea: Developing Drugs for Treatment
Guidance DocumentAugust 18, 2015Center for Drug Evaluation and Research
Nonclinical Evaluation of Endocrine-Related Drug Toxicity
Guidance DocumentSeptember 9, 2015Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox